Literature DB >> 29383612

Palliative Management of Peritoneal Metastases.

Laura A Lambert1, Jason Wiseman2.   

Abstract

Despite significant recent advances in the management of peritoneal carcinomatosis, this diagnosis still is accompanied frequently by a grim survival prognosis, often measured in weeks to months. The poor prognosis also is accompanied often by complications and symptoms that have a dramatic impact on quality of life and are challenging to the managing health care provider and devastating to loved ones caring for the person who is suffering. Consequently, management of carcinomatosis often revolves around palliation of symptoms such as bowel obstruction, nausea, pain, fatigue, and cachexia as well as emotional and existential concerns. This article reviews several palliative treatment options for some of the more common symptoms and complications associated with advanced, incurable peritoneal carcinomatosis. Although readers should recognize that carcinomatosis is no longer an imminent death sentence, providers caring for patients with peritoneal carcinomatosis also must be well-versed in the palliative management of this condition and recognize the utility of early palliative care referral in this setting.

Entities:  

Mesh:

Year:  2018        PMID: 29383612     DOI: 10.1245/s10434-018-6335-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

Review 1.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

2.  Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.

Authors:  Marcela A Haro; Allison M Dyevoich; James P Phipps; Karen M Haas
Journal:  Cancer Res       Date:  2018-09-17       Impact factor: 12.701

Review 3.  Analgesia for Gynecologic Oncologic Surgeries: A Narrative Review.

Authors:  Kaiwal Patel; Sukhman Shergill; Nalini Vadivelu; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2022-02-03

4.  Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis - initial trial preliminary report.

Authors:  Maciej Nowacki; Katarzyna Nowacka; Iwona Głowacka; Barbara Zegarska; Wojciech Zegarski
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

Review 5.  Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis.

Authors:  Rami Archid; Wiebke Solass; Clemens Tempfer; Alfred Königsrainer; Michael Adolph; Marc A Reymond; Robert B Wilson
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

6.  Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study.

Authors:  Jan Bednarsch; Zoltan Czigany; Daniel Heise; Henning Zimmermann; Joerg Boecker; Tom Florian Ulmer; Ulf Peter Neumann; Christian Klink
Journal:  World J Surg Oncol       Date:  2020-01-31       Impact factor: 2.754

7.  Endothelin-1 Exhibiting Pro-Nociceptive and Pro-Peristaltic Activities Is Increased in Peritoneal Carcinomatosis.

Authors:  Céline Greco; Lilian Basso; Cléo Désormeaux; Audren Fournel; Benedicte Demuynck; Leila Lafendi; Sylvie Chapiro; Antoinette Lemoine; Ying-Ying Zhu; Claude Knauf; Nicolas Cenac; Claude Boucheix; Gilles Dietrich
Journal:  Front Pain Res (Lausanne)       Date:  2021-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.